Evidence map›Paper›PMID 39840837›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2025

Human Endogenous Retrovirus K in Astrocytes Is Altered in Parkinson's Disease.

YuHong Fu, Gabrielle L Adler, Priscilla Youssef, Katherine Phan, Glenda M Halliday, Nicolas Dzamko, Woojin Scott Kim

Abstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

YuHong FuBrain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.
Gabrielle L AdlerBrain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.
Priscilla YoussefBrain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.
Katherine PhanBrain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.
Glenda M HallidayBrain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0003-0422-8398
Nicolas DzamkoBrain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0002-9121-0294
Woojin Scott KimBrain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0002-4707-933X

Funding

Brain Tissue Resource Centre for Alcohol ResearchR28AA012725 · NIAAA · UNIVERSITY OF SYDNEY · PI Greg Trevor Sutherland · 2012 to 2026
$7.0M
National Health and Medical Research Council 1176607National Health and Medical Research Council 132524NIAAA NIH HHS R28 AA012725NIH HHS R28AA012725
6 · The paper itself

Abstract

backgroundParkinson's disease (PD) is the most common neurodegenerative movement disease. Human endogenous retroviruses (HERVs) are proviral remnants of ancient retroviral infection of germ cells that now constitute about 8% of the human genome. Under certain disease conditions, HERV genes are activated and partake in the disease process. However, virtually nothing is known about the pathological relationship, if any, between HERV and PD.

objectiveThe objectives of this study were to unravel the pathological relationship between human endogenous retrovirus K (HERV-K) and PD, determine the localization of HERV-K in the brain, determine whether HERV-K levels are altered in PD brain and blood, and examine whether HERV-K could serve as a biomarker for PD.

methodsIn situ HERV-K and glial fibrillary acidic protein (GFAP) expression in the superior frontal and fusiform cortices of PD and control brain were analyzed using immunofluorescence and confocal microscopy. HERV-K load and copy number in PD and control blood were measured by digital droplet polymerase chain reaction and GFAP by single-molecule array. HERV-K load was analyzed in relation to the Hoehn and Yahr Scale and Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III.

resultsHERV-K is predominantly expressed in astrocytes and colocalized with astrocytic GFAP, with decreased expression of both HERV-K and GFAP in PD brain compared with controls. Consistent with this, HERV-K levels were decreased in PD blood compared with controls and were correlated to blood GFAP levels. HERV-K levels were inversely correlated to PD severity and duration.

conclusionsThese findings suggest that HERV-K is related to astrocyte function and to PD progression, and that HERV-K could be neuroprotective. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

AstrocytesEndogenous RetrovirusesParkinson DiseaseAgedBrainFemaleGlial Fibrillary Acidic ProteinHumansMaleMiddle AgedGlial Fibrillary Acidic ProteinastrocytebiomarkersenvelopeGFAPHERV‐Khuman endogenous retrovirusParkinson's disease

Identifiers

PMID39840837
PMCPMC12006878

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.